Nicole Basset-Seguin Selected Research

Metabolic Bone Diseases (Osteopenia)

12/2018

Osteopenia and fractures associated with long-term therapy with MEK inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicole Basset-Seguin Research Topics

Disease

22	Melanoma (Melanoma, Malignant) 01/2022 - 08/2005
16	Basal Cell Carcinoma (Rodent Ulcer) 05/2022 - 07/2006
8	Neoplasms (Cancer) 05/2021 - 04/2010
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021 - 09/2011
6	Skin Neoplasms (Skin Cancer) 03/2019 - 08/2005
6	Actinic Keratosis 05/2017 - 01/2007
3	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2014
3	Bowen's Disease (Disease, Bowen) 06/2016 - 01/2007
2	Pain (Aches) 12/2018 - 10/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Disease Progression 01/2017 - 08/2014
1	Dermatofibrosarcoma 05/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2020
1	Carcinoma (Carcinomatosis) 06/2019
1	Keratoacanthoma 06/2019
1	Metabolic Bone Diseases (Osteopenia) 12/2018
1	Osteoporosis 12/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Insulin Resistance 01/2018
1	Hyperplasia 12/2017
1	Cushing Syndrome 12/2017
1	Pituitary Neoplasms (Pituitary Adenoma) 12/2017
1	Dropped Head Syndrome 10/2017
1	Fatigue 10/2017
1	Muscle Hypotonia (Hypotonia) 10/2017
1	Muscular Diseases (Myopathy) 10/2017
1	Confusion (Bewilderment) 11/2016
1	Skin Diseases (Skin Disease) 07/2015
1	Albinism 11/2011
1	Pigmented Nevus (Melanocytic Nevus) 10/2010
1	Neoplasm Micrometastasis 10/2009
1	Cicatrix (Scar) 08/2008

Drug/Important Bio-Agent (IBA)

9	HhAntag691IBA 01/2022 - 08/2014
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2017 - 01/2007
4	Biomarkers (Surrogate Marker)IBA 01/2016 - 10/2009
3	sonidegibIBA 05/2022 - 10/2016
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 10/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 03/2015
3	pembrolizumabIBA 10/2021 - 01/2020
3	Immune Checkpoint InhibitorsIBA 12/2017 - 10/2017
3	VemurafenibIBA 10/2017 - 02/2014
3	Monophenol Monooxygenase (Tyrosinase)IBA 11/2011 - 03/2007
2	Messenger RNA (mRNA)IBA 06/2018 - 01/2012
2	Interleukin-2 (IL2)IBA 01/2018 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 10/2009
2	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2016 - 10/2009
2	Biological ProductsIBA 10/2010 - 03/2007
2	Type 1 Melanocortin ReceptorIBA 07/2006 - 08/2005
1	Tyrosine Kinase InhibitorsIBA 05/2021
1	Imatinib Mesylate (Gleevec)FDA Link 05/2021
1	cemiplimabIBA 01/2021
1	LigandsIBA 10/2020
1	Acitretin FDA Link 06/2019
1	DNA (Deoxyribonucleic Acid)IBA 03/2019
1	Sunscreening Agents (Sunscreens)IBA 03/2019
1	Cholecalciferol (Vitamin D3)FDA Link 12/2018
1	Zoledronic Acid (Zometa)FDA Link 12/2018
1	CalciumIBA 12/2018
1	AntibodiesIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2017
1	Hydrocortisone (Cortisol)FDA LinkGeneric 12/2017
1	NivolumabIBA 11/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017
1	cobimetinibIBA 10/2017
1	parkin proteinIBA 03/2016
1	Metalloproteases (Metalloproteinases)IBA 01/2016
1	CreatinineIBA 01/2016
1	IpilimumabIBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	ParaffinIBA 01/2012
1	Cetuximab (Erbitux)FDA Link 09/2011
1	ErbB Receptors (EGF Receptor)IBA 09/2011
1	Monoclonal AntibodiesIBA 09/2011
1	Protein PrecursorsIBA 04/2010
1	EnzymesIBA 04/2010
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 04/2010
1	Genetic Markers (Genetic Marker)IBA 12/2009
1	AntigensIBA 10/2009
1	Differentiation AntigensIBA 10/2009
1	Complement System Proteins (Complement)IBA 09/2008
1	methyl 5-aminolevulinateIBA 09/2008
1	leucylleucine (Leu-Leu)IBA 09/2008
1	phenylalanylleucineIBA 09/2008
1	Sulfides (Thioethers)IBA 08/2008
1	Chemokine ReceptorsIBA 04/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2007

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2007
4	Immunotherapy 01/2022 - 01/2018
4	Photochemotherapy (Photodynamic Therapy) 06/2016 - 01/2007
3	Drug Therapy (Chemotherapy) 10/2020 - 09/2011
2	Neoadjuvant Therapy 05/2021 - 05/2021
2	Duration of Therapy 01/2018 - 11/2016
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Rejuvenation 07/2015
1	Radiotherapy 03/2015
1	Cryotherapy (Therapy, Cold) 09/2008